この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2014/4/91 分で読めます
Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Draft Guidance for Industry and Food and Drug Administration Staff; Extension of Comment Period
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is extending to May 7, 2014, the comment period for the notice that appeared in the Federal Register of January 7, 2014 (79 FR 830). In the notice, FDA requested comments on a draft guidance document entitled "Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use." The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →